EDP-322
- Generic Name
- EDP-322
Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers
- First Posted Date
- 2009-10-06
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 52
- Registration Number
- NCT00990145
- Locations
- 🇺🇸
PPD Phase I Unit, Austin, Texas, United States
Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers
Phase 1
Completed
- Conditions
- Skin and Soft Tissue InfectionsMethicillin-resistant Staphylococcus Aureus
- First Posted Date
- 2009-10-06
- Last Posted Date
- 2009-10-06
- Lead Sponsor
- Enanta Pharmaceuticals, Inc
- Target Recruit Count
- 67
- Registration Number
- NCT00989872
- Locations
- 🇺🇸
PPD Phase I Unit, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath